The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 153.80
Bid: 152.20
Ask: 153.80
Change: 2.20 (1.45%)
Spread: 1.60 (1.051%)
Open: 153.80
High: 153.80
Low: 153.80
Prev. Close: 151.60
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2015 Interim Highlights

26 Aug 2015 07:00

RNS Number : 0824X
Apax Global Alpha Limited
26 August 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

 26 August 2015 FOR IMMEDIATE RELEASE

Apax Global Alpha Limited

Unaudited Results for the period ended 30 June 2015

 

The financial statements cover the period from 2 March 2015 to 30 June 2015. Where we discuss the trading period to 31 December 2014 this refers to the period as PCV Lux S.C.A ("PCV") and its subsidiaries (collectively the "PCV Group") prior to the acquisition by AGA. Irrespective of whether the text refers to AGA or PCV, references to the trading period from 1 January or 1 April to 30 June include trading as PCV prior to the transfer of assets to AGA following the acquisition and listing on 15 June 2015.

 

For further information regarding the announcement of AGA's 2015 Interim Reports and Accounts, including the details for today's analyst and investor call at 9.30am (BST), please visit www.apaxglobalalpha.com/investor-information/calendar

 

Financial highlights for six months to 30 June 2015

· Adjusted NAV, excluding performance fee reserves, increased by €65.0 million pro forma to €877.9 million due to investment performance, equivalent to a like-for-like increase of 8.0%

· Adjusted NAV per share is €1.79 (equivalent to £1.27 at 30 June 2015), up from €1.66 pro forma after normalising for the IPO proceeds

· In the six months to 30 June 2015, the invested portfolio of AGA has achieved a gross IRR of 35.6%, outperforming the benchmarks (1) by 29.2% in the same time period

· Share price of 125.38p as at 30 June 2015, + 5.2% since the IPO offer price of 119.20p

· The IPO raised the maximum gross proceeds of €300 million (2) and was over-subscribed

· Following the cash injection from the IPO, AGA is 65% invested (€572.8 million) as per 30 June 2015

 

Investment highlights for six months to 30 June 2015

· Well balanced invested portfolio: Private Equity (46%) and Derived Investments (54%)

· Exposure to all Apax Partners' focus sectors. As per 30 June 2015, Tech & Telco is the sector with the strongest weight, accounting for 37% of the invested portfolio

· Geographic bias towards North America representing 59% of the invested portfolio as at 30 June 2015

· The Investment Manager has highlighted the following in Private Equity portfolio

o Apax Private Equity funds are exploiting strong exit markets and have returned €10.6 million to AGA over the last six months

o Through its holding in AVIII and AMI, AGA is expected to indirectly invest €71.5m(3) in five new Private Equity investments

· The Investment Manager has highlighted the following in Derived Investments

o Exited two debt investments and three listed equity investments, realising a total of €89.0 million

o In H1 2015, AGA made six investments in debt and one in listed equities totalling €76.3 million in the period to 30 June 2015

 

Commenting on the results, Tim Breedon CBE, Chairman of Apax Global Alpha, said:

"I am delighted to present our first results since the company's successful move on to the public markets. AGA raised €300 million (2) from its listing on the London Stock Exchange in June and the offer was over-subscribed. This allows the company to pursue its strategy of investing in Apax private equity funds and targeting investments in other asset classes derived from those private equity activities. The Company is on track to deliver its target Total Shareholder Return and dividend yield once fully invested.

We would like to take this opportunity to welcome the many new investors into AGA who have not previously had the opportunity to gain exposure to our unique investment approach, and to thank our original investors for their continued support."

Commenting on AGA's outlook, Nico Hansen, CIO of Apax Partners, said:

"We are actively identifying new opportunities to invest or commit the net proceeds from the IPO within the 6-12 months post-listing. While the general pricing environment remains elevated, the Apax Private Equity funds are finding good value opportunities, particularly in Europe. In North America and the Emerging Markets, they continue to be focused on under-appreciated niches. At the same time, AGA continues to see good flow in Derived Investments and we have identified a number of attractive investment opportunities where we can exploit market inefficiencies as they arise."

 

 

Financial highlights

 

Private Equity

Derived Investments

Cash and Legacy Hedge Funds

Others

Total

 

€ million

€ million

€ million

€ million

€ million

NAV as at 31 December 2014

198.8

294.8

38.7

4.9

537.2

+ Net IPO Proceeds

-

-

275.0

-

275.0

+ Investments

33.5

76.3

(109.8)

-

0.0

- Divestments

(10.6)

(83.0)

105.6

-

12.0

+ Interest and dividend income

-

-

8.7

-

8.7

+/- Unrealised Gains

35.6

5.4

-

-

41.0

+/- FX Gains

6.5

15.5

-

-

22.0

+/- Costs and Others

-

-

5.1

(15.1)

(10.0)

NAV as of 30 June 2015

263.8

309.0

323.3

(10.2)

885.9

+/- Change in Performance Fee Reserve

(2.6)

(5.4)

-

-

(8.0)

Adjusted NAV as of 30 June 2015

261.2

303.6

323.3

(10.2)

877.9

 

 

Portfolio performance during 1H 2015

 

Gross IRR

%

Outperformance

%

Benchmarks

%

Private Equity

46.0

39.2

6.8

 

 

 

 

Derived Investments

27.7

21.5

6.2

- Debt

24.3

19.0

5.2

- Equities

35.2

26.8

8.4

 

 

 

 

Total

35.6

29.2

6.5

 

 

Invested portfolio analysis at 30 June 2015

Asset class

(excluding hedge funds)

€m

€m

%

%

Private Equity

263.8

 

46

 

- AEVI

 

7.7

 

1

- AE VII

 

88.8

 

16

- AE VIII

 

167.3

 

29

Derived Investments

309.0

 

54

 

- Debt

 

237.5

 

41

- Equities

 

71.5

 

13

Total

572.8

572.8

100.0

 

 

 

 

Sector mix

€m

Portfolio

Private Equity

Derived Investments

%

%

%

Tech & Telco

211.1

36.8

34.7

38.7

Services

132.7

23.2

32.6

15.1

Consumer

124.4

21.7

12.0

30.1

Healthcare

92.9

16.2

17.7

14.9

Other

11.7

2.1

3.0

1.2

Total

572.8

100.0

100.0

100.0

 

 

Geographic analysis

€m

Portfolio

Private Equity

Derived Investments

%

%

%

North America

338.4

59.1

55.1

62.5

UK

62.2

10.9

10.8

11

Switzerland

13.4

2.3

0.1

4.2

Rest of Europe

76.5

13.4

21.6

6.4

India

52.3

9.1

6.1

11.7

China

17.5

3.0

1.6

4.2

RoW

12.5

2.2

4.7

0.0

Total

572.8

100.0

100.0

100.0

 

 

Summary of top 10 investments in Private Equity and Derived Investments

 

Valuation

€m

% of NAV

% of invested portfolio

Top 10 Private Equity

 

 

 

One Call/ Align

29.3

3%

5%

Garda

22.8

3%

4%

GlobalLogic

20.9

2%

4%

EVRY

19.3

2%

3%

Exact Software

17.5

2%

3%

Acelity (Kinetic Concepts)

13.0

1%

2%

Answers Corporation

12.7

1%

2%

Cole Haan

12.3

1%

2%

Auto Trader Group

10.4

1%

2%

Shriram City Union

10.2

1%

2%

Other

95.4

11%

17%

Total private equity

263.8

30%

46%

 

 

 

 

Top 10 Derived Investments

 

 

 

Exact Software

25.2

3%

4%

Answers Corporation

22.7

3%

4%

Epicor

21.7

2%

4%

Compuware

20.8

2%

4%

Genex

20.4

2%

4%

Rentpath

18.5

2%

3%

Advantage Sales & Marketing

18.0

2%

3%

Paradigm

17.9

2%

3%

Greene King

15.9

2%

3%

Unilabs

13.1

1%

2%

Other

114.8

13%

20%

Total derived investments

309.0

35%

54%

 

 

 

 

Total investments

572.8

65%

100%

Cash

320.7(4)

36%

0%

Legacy hedge funds

2.6

0%

0%

Net current assets

(10.2)

(1%)

0%

Total NAV

885.9

100%

0%

 

Contact details

Investor Relations

Lorraine Rees

Telephone: +44 (0)20 7872 6300

Email: investor.relations@apaxglobalalpha.com

 

Media enquiries (Apax Global Alpha Ltd)

Alex Jones, Greenbrook Communications

Telephone: +44 (0)20 7952 2000

Email: aga@greenbrookpr.com

Media enquiries (Apax Partners LLP)

Alex Wessendorff

Telephone: +44 (0)20 7872 6461

Email: alex.wessendorff@apax.com

 

Notes

 

1. The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States.

2. This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

Footnotes

1. References to benchmarks refer to MSCI Net Total Return World Index for Private Equity and Equities, and BAML US HY Master II Index for debt.

 

2. Total proceeds of €300m were raised based on the FX rate at the date of allocation prior to IPO. A total of €301.4m was raised when the proceeds were recalculated to euro based on the exchange rate at close of business on the date of listing the 15 June 2015.

 

3. Excludes a €10.5m acquisition by AGA of a carried interest stake in AE VII. Of the expected €71.5m, €23.0m has been funded as of 30 June 2015, with the remaining €48.5m relating to transactions of the Apax Private Equity Funds that were funded via capital call facilities, pending capital calls from investors.

 

4. Comprises €278.8m held in AGA and €41.9m held in subsidiaries.

 

About Apax Global Alpha Ltd

AGA is a Guernsey closed-ended investment company that listed on the London Stock Exchange on 15th June 2015.

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Shareholder Return (TSR), across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value (NAV), once fully invested.

The investment policy of the Company is to make private equity investments in Apax Funds and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cashflow requirements, the dividend policy and other factors.

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm. It operates globally and has more than 30 years of investing experience. Apax Partners has advised funds that total over €34 billion in aggregate as at 30 June 2015. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide long‐term equity financing to build and strengthen world‐class companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners LLP is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEEESIFISEEA
Date   Source Headline
7th May 20247:00 amRNSApax IX agrees to sell Healthium
2nd May 20247:00 amRNSAudit Committee Change
2nd May 20247:00 amRNSResult of AGM
2nd May 20247:00 amRNSQuarterly Results to 31 March 2024
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.